TUDCA inhibits the elevation of Grp78, phospho-PERK and phospho-eIF2α in obese mice, leading to alleviation of obesity-induced cardiac hypertrophy, compromised fractional shortening and cardiomyocyte contractile [39]. Here, HSPA5 is linked to obesity disorder.